HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoyoshi Yano Selected Research

Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)

10/2007Genetic background of Japanese patients with adult-onset storage diseases in the liver.
4/2005Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan.
9/2004Improvement of serum bilirubin levels after venesection in a patient with Dubin-Johnson syndrome and HCV-positive chronic liver disease.
1/2003Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motoyoshi Yano Research Topics

Disease

9Hepatolenticular Degeneration (Wilson's Disease)
03/2017 - 10/2005
7Chronic Hepatitis C
05/2011 - 01/2002
6Iron Overload
10/2018 - 09/2004
5Hemochromatosis (Bronze Diabetes)
01/2010 - 03/2005
4Hepatitis
04/2010 - 08/2006
4Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)
10/2007 - 01/2003
3Liver Diseases (Liver Disease)
01/2010 - 09/2004
2Hyperferritinemia
10/2018 - 09/2005
2Liver Failure
09/2011 - 01/2010
2Hepatitis B
04/2010 - 04/2007
2Chronic Hepatitis (Chronic Active Hepatitis)
03/2009 - 04/2007
2Hyperbilirubinemia
09/2004 - 01/2003
1Atrophy
10/2018
1Anemia
02/2014
1Fibrosis (Cirrhosis)
09/2011
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2010
1Brain Diseases (Brain Disorder)
01/2010
1Fatty Liver
06/2009
1Chronic Hepatitis B
04/2007
1Massive Hepatic Necrosis
08/2006
1Hemophilia A (Haemophilia)
03/2005
1Diabetes Mellitus
03/2005
1Jaundice (Icterus)
09/2004
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2002
1Inflammation (Inflammations)
01/2002

Drug/Important Bio-Agent (IBA)

12IronIBA
10/2018 - 01/2002
8CopperIBA
03/2017 - 08/2006
3Familial apoceruloplasmin deficiencyIBA
09/2013 - 09/2006
3ATP-Binding Cassette Sub-Family B Member 4IBA
04/2005 - 01/2003
2metal transporting protein 1 (ferroportin)IBA
10/2018 - 09/2005
2EnzymesIBA
02/2014 - 01/2010
2Idiopathic Copper ToxicosisIBA
09/2013 - 09/2011
2Lamivudine (Epivir)FDA Link
04/2010 - 04/2007
2Transaminases (Aminotransferases)IBA
01/2010 - 01/2002
2Alanine Transaminase (SGPT)IBA
09/2004 - 06/2004
1HepcidinsIBA
01/2010
1Ferritins (Ferritin)IBA
01/2010
1Fixatives (Pickling Agents)IBA
06/2009
1Coloring Agents (Dyes)IBA
06/2009
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
03/2009
1Malondialdehyde (Propanedial)IBA
08/2006
1Heme (Haem)IBA
08/2006
1Trientine (Trien)FDA Link
10/2005
1Transferrin (beta 2 Transferrin)IBA
09/2005
1Ribavirin (Virazole)FDA LinkGeneric
03/2005
1Blood Coagulation Factors (Coagulation Factor)IBA
03/2005
1Transferrin Receptors (Transferrin Receptor)IBA
03/2005
1Glucose (Dextrose)FDA LinkGeneric
03/2005
1BilirubinIBA
09/2004
1InterferonsIBA
09/2004

Therapy/Procedure

7Therapeutics
05/2011 - 06/2004
1Drug Therapy (Chemotherapy)
01/2010
1Aftercare (After-Treatment)
09/2006